A carregar...
Oxaliplatin and infliximab synergize to induce regression of colon cancer
There is currently a lack of therapeutic options for patients with advanced colon cancer. Although certain chemotherapies are able to suppress the progression slightly, the response rate is low, and side effects of treatment and tumor recurrence continue to present problems for clinicians. Tumor nec...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5774490/ https://ncbi.nlm.nih.gov/pubmed/29434844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7468 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|